Sanofi (SNY) Gets FDA Approval for Sklice Lotion Head Lice Treatment

Sanofi (NYSE: SNY) announced today that the U.S. Food and Drug Administration (FDA) has approved Sklice (ivermectin) lotion, 0.5% for the topical treatment of head lice, in patients 6 months of age and older. Effective and well-tolerated, Sklice Lotion treats lice in most patients with a single 10-minute application of the lotion, without nit combing.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• FDA authorizes 11 ZYN Ultra nicotine pouches for Philip Morris
• enVVeno Medical (NVNO) files $100M mixed shelf
• Boeing names Ryan Shedd as new SVP and controller